Related references
Note: Only part of the references are listed.Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+, cells in the draining lymph nodes
Shelley Gorman et al.
JOURNAL OF IMMUNOLOGY (2007)
Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation
Sheng Chen et al.
JOURNAL OF IMMUNOLOGY (2007)
1,25-dihydroxyvitamin D-3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells
Giuseppe Penna et al.
JOURNAL OF IMMUNOLOGY (2007)
Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol
Giuseppe Penna et al.
JOURNAL OF IMMUNOLOGY (2006)
IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis
Karen M. Spach et al.
JOURNAL OF IMMUNOLOGY (2006)
Cutting edge:: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression
TT Wang et al.
JOURNAL OF IMMUNOLOGY (2004)
A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development
N Giarratana et al.
JOURNAL OF IMMUNOLOGY (2004)
Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells
M Hewison et al.
JOURNAL OF IMMUNOLOGY (2003)
1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells
A Boonstra et al.
JOURNAL OF IMMUNOLOGY (2001)
Regulatory T cells induced by 1α,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance
S Gregori et al.
JOURNAL OF IMMUNOLOGY (2001)
1 alpha,25-dihydroxyvitamin D-3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation
G Penna et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
